Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep891 | Pituitary - Clinical | ECE2016

Non-alcoholic fatty liver disease in patients with biochemically cured Cushing’s disease and non-functioning pituitary adenomas: role of adrenal insufficiency and growth hormone deficiency

Auer Matthias K , Stieg Mareike R , Stalla Gunter K

Objective: Nonalcoholic fatty liver disease (NAFLD) is a hallmark of the metabolic syndrome and has been shown to be an independent predictor of cardiovascular mortality. Although glucocorticoids and growth hormone are known to be implicated in its pathophysiology, it has only rarely been investigated in the context of patients with pituitary insufficiency or former cortisol excess.Design: Case-control study, including patients with biochemically control...

ea0037gp.05.04 | Developmental and paediatric endocrinology | ECE2015

Pilot study on the effects of cross-sex hormone treatment in transsexual persons on metabolism by means of metabolomics profiling

Auer Matthias K , Xu Tao , Roepke Yasmin , Stalla Gunter K , Stieg Mareike , Van Caenegem Eva , Prehn Cornelia , Wang-Sattler Rui , Adamski Jerzy , T'sjoen Guy

Introduction: Sex steroid hormones exert a wide range of effects on metabolism. New techniques such as metabolomic profiling allow for a deeper insight into metabolic regulation. In epidemiological samples it has been demonstrated that most of these metabolites show sex-specific differences. However, if these differences are attributable to the effects of sex hormones or genetics is little understood so far.Methods: We performed targeted metabolomics pro...

ea0073aep6 | Adrenal and Cardiovascular Endocrinology | ECE2021

Salivary profiles of 11-oxygenated androgens follow a diurnal rhythm in patients with congenital adrenal hyperplasia

Nowotny Hanna F. , Auer Matthias K. , Lottspeich Christian , Schmidt Heinrich , Dubinski Ilja , Bidlingmaier Martin , Adaway Jo , Hawley James , Keevil Brian , Reisch Nicole

BackgroundRoutine biochemical assessment in patients with congenital adrenal hyperplasia (CAH) includes measurement of serum 17–hydroxyprogesterone (17OHP), androstenedione (A4) and testosterone (T) and their metabolites in urine. Several studies have also described 11–oxygenated 19–carbon (110 × C19) steroids as a clinically relevant androgenetic source and highlighted their potential as markers for evaluation of adrenal androgen exc...

ea0081mte11 | Endocrine treatment in transgenders - when, who and how? | ECE2022

Endocrine treatment in transgenders - when, who and how?

Auer Matthias

Treatment of transgender patients has gained increasing importance in outpatient endocrinological care due to a steadily rising influx of patients in recent years. Many gaps in knowledge regarding hormonal therapy have been filled in recent years thanks to a growing body of literature based on larger cohort studies. Nowadays therapy can be regarded as safe and effective. While puberty arrest and peripubertal hormone treatment in transgender youth has gained growing acceptance ...

ea0041ep905 | Pituitary - Clinical | ECE2016

Incidental finding of “Empty Sella” and prevalence of endocrine disturbances – a systematic review

Stieg Mareike , Auer Matthias , Stalla Gunter K , Kopczak Anna

Neuroimaging techniques have improved over the last years; hence an “empty sella” is more often incidentally diagnosed. The term “empty sella” describes a missing pituitary gland in the sella turcica. Up to now, it is not known if routine endocrine assessment is necessary in patients with primary empty sella syndrome (PES) without clinical suspicion or history of neuroendocrine disorders.We performed a systematic literature research u...

ea0032p333 | Developmental Endocrinology | ECE2013

Changes in sexual orientation in gender identity disorder: evaluation of their association to sex reassignment surgery and cross-sex hormone treatment

Auer Matthias , Fuss Johannes , Athanasoulia Anasthasia , Stalla Guenter , Sievers Caroline

Objective: Sexual orientation in males and females is considered to be determined in early life and to be virtually unchangeable in the course of adulthood. In contrast some transsexuals report a change in their sexual orientation most overt following sex reassignment procedures. The reason for this phenomenon is unknown.Methods: We asked 106 transsexual (66 MtF and 40 FtM) patients from our endocrine outpatient clinic to complete a questionnaire, retros...

ea0029p1588 | Thyroid (non-cancer) | ICEECE2012

Linking thyroid and central nervous system functions of cathepsin K: Implications for non-classical thyroid regulation

Dauth S. , Rehders M. , Sirbulescu R. , Wirth E. , Braun D. , Batbajar B. , Schweizer U. , Brocker-Preuss M. , Fuhrer D. , Saftig P. , Jordans S. , Brix K.

Cathepsin K is a cysteine protease known for its importance in bone remodelling. Inhibitors of cathepsin K are in clinical trials for osteoporosis treatment, but side effects included altered levels of related cathepsins in peripheral organs and in the central nervous system (CNS). Importantly, cathepsin K has been identified not only in osteoclasts but also in most epithelia and, recently, in brain parenchyma. Lately, we have also shown that cathepsin K deficiency in mice ind...

ea0090rc9.4 | Rapid Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

Dysregulations in CLOCK genes in immune cells in congenital adrenal hyperplasia depending on the type of glucocorticoid replacement regimens

Ju Jing , F. Nowotny Hanna , Tschaidse Lea , Auer Matthias , Reisch Nicole

Background: Glucocorticoid (GC) substitution therapy in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is not able to perfectly mimic physiological circadian profiles. Unphysiologically high doses, as well as unphysiological variations in GC concentrations might cause adverSemetabolic, cardiovascular and immunological effects. Previous publications have demonstrated dysregulations in immune cell profiles of patients with primary adrenal ins...

ea0090p4 | Adrenal and Cardiovascular Endocrinology | ECE2023

Hypogonadism in men with congenital adrenal hyperplasia. A retrospective longitudinal analysis with a special focus on testicular adrenal rest tumors and 11-oxygenated androgens

Auer Matthias , Lottspeich Christian , Bidlingmaier Martin , F. Nowotny Hanna , Tschaidse Lea , Auchus Richard , Reisch Nicole

Background: Hypogonadism is frequent in men with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD). It has recently been demonstrated that testicular adrenal rest tumors (TART) are a source of 11-oxygenated androgens that might impair testicular function, in addition to their local compressive effects. Data on long-term course of testicular function in men with 21OHD and the role of potential influential factors such as presence of TART and 11-oxyge...

ea0090p287 | Adrenal and Cardiovascular Endocrinology | ECE2023

Perception of female patients with congenital adrenal hyperplasia and their parents on genital surgery: a retrospective survey

Tschaidse Lea , Sappl Andrea , Auer Matthias , Lottspeich Christian , Nowotny Hanna F. , Reisch Nicole

Background: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is associated with ACTH-driven adrenal androgen excess. In women with classic CAH, this regularly causes prenatal virilisation of the external genitalia, commonly corrected by genital surgery during the first years of life. This practice, however, has been questioned and is discussed highly controversial. The aim of this study was to retrospectively assess the perspective of affected patients and...